Median survival for pts w/#VEXAS➡️10 years Predictors of mortality w/VEXAS: 👉p.MetVal mutation HR 3.5 (95%CI, 1.4-8.5) 👉transfusion dependency HR 2.59 (95%CI, 0.94-7.09) 👉⬇️risk w/ear chondritis HR 0.26 (95%CI,0.09-0.6) @marcelaferrada #ACR21 @rheumnow Abstr#1426 #ACRbest